At Manningham Medical Centre, you can find all the data about Sirtex Medical News. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Sirtex - Press Releases

    https://www.sirtex.com/us/news/press-releases/
    WOBURN, Mass. (October 11, 2021) – Sirtex Medical (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, announced today that the first procedure of selective …

Sirtex - News

    https://www.sirtex.com/us/news/
    News. Sirtex wants medical professionals and patients to understand how our products can help improve clinical outcomes and the quality of life for people with liver …

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 …

    https://finance.yahoo.com/news/sirtex-medical-secures-positive-approval-130000810.html
    Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that the Brazilian National Agency of Supplementary Health (ANS) …

Sirtex Medical and Grand Pharmaceutical Group Limited …

    https://www.prnewswire.com/news-releases/sirtex-medical-and-grand-pharmaceutical-group-limited-receive-nda-approval-of-sir-spheres-y-90-resin-microspheres-in-china-from-the-national-medical-products-administration-301478731.html
    WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its …

Sirtex Medical and BlackSwan Vascular, Inc. announce …

    https://www.prnewswire.com/news-releases/sirtex-medical-and-blackswan-vascular-inc-announce-first-patient-enrolled-in-pivotal-lava-study-301271690.html
    Apr 19, 2021, 12:04 ET. WOBURN, Mass., April 19, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and …

Sirtex - News Item

    https://www.sirtex.com/us/news/press-releases/news-item?id=7699
    Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres ® Y-90 resin microspheres in China from the National Medical …

Sirtex Medical announces collaboration update with …

    https://www.prnewswire.com/news-releases/sirtex-medical-announces-collaboration-update-with-oncosec-medical-301210378.html
    Collaboration provides Sirtex the right to co-promote OncoSec lead product candidate TAVO™ for the treatment of advanced melanoma. WOBURN, Mass., Jan. 19, …

Sirtex - News Item

    https://www.sirtex.com/us/news/press-releases/news-item?id=7619
    Sirtex’s current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 100,000 doses have been …

Sirtex Medical | Company Overview & News - Forbes

    https://www.forbes.com/companies/sirtex-medical/
    Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments. It offers targeted radiation therapy known as SIR …

Sirtex - Leadership Team

    https://www.sirtex.com/us/about-sirtex/leadership-team/
    The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved …



Need more information about Sirtex Medical News?

At Manningham Medical Centre, we collected data on more than just Sirtex Medical News. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.